|
|
|
|
| LEADER |
01029nam#a2200313#a#4500 |
| 001 |
OUN156401 |
| 003 |
OUN |
| 005 |
20060601105400 |
| 008 |
980522s1997 xxu |||| ||eng d |
| 020 |
# |
# |
|a 9211301831
|
| 040 |
# |
# |
|a OUN
|
| 080 |
# |
# |
|a 615.11
|
| 092 |
# |
# |
|s NU
|c 615.11
|l N962c
|
| 110 |
2 |
# |
|a Naciones Unidas.
|b Departamento de Coordinación de Políticas y Desarrollo Sostenible.
|
| 245 |
1 |
0 |
|a Consolidated lits of products whose consumption and/or sale have been banned, whithdrawn, severely restricted or not approved by Governments :
|b pharmaceuticals /
|c Department for Policy Coordination and Sustainable Development.
|
| 250 |
# |
# |
|a 6a. ed.
|
| 260 |
# |
# |
|a New York :
|b UN,
|c 1997.
|
| 300 |
# |
# |
|a xxiii, 381 p.
|
| 650 |
# |
4 |
|a FARMACOPEAS
|
| 650 |
# |
4 |
|a PRODUCTOS FARMACEUTICOS
|
| 650 |
# |
4 |
|a INDUSTRIA FARMACEUTICA
|
| 650 |
# |
4 |
|a BANNED
|
| 650 |
# |
4 |
|a ESPECIFICACIONES
|
| 866 |
0 |
# |
|a 1 ej.
|
| 907 |
# |
# |
|a NORMALEG
|
| 930 |
# |
# |
|a 95369
|p v
|x r
|
| 942 |
# |
# |
|c IMP
|
| 952 |
# |
# |
|p OUN95369
|a OUN
|b OUN
|o NU 615.11 N962C
|y IMP
|
| 999 |
# |
# |
|a NORMA
|
